M. Claustres

1.7k total citations · 1 hit paper
18 papers, 1.0k citations indexed

About

M. Claustres is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Claustres has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Claustres's work include Cystic Fibrosis Research Advances (4 papers), Hemophilia Treatment and Research (3 papers) and Muscle Physiology and Disorders (2 papers). M. Claustres is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Hemophilia Treatment and Research (3 papers) and Muscle Physiology and Disorders (2 papers). M. Claustres collaborates with scholars based in France, Spain and Croatia. M. Claustres's co-authors include Miguel Chillón, Willy Lissens, C. Verlingue, Bernard Mercier, Lluís Bassas, S. Silber, Teresa Casals, Marie‐Catherine Romey, Thierry Soussi and Chikashi Ishioka and has published in prestigious journals such as New England Journal of Medicine, Nature reviews. Cancer and Thrombosis and Haemostasis.

In The Last Decade

M. Claustres

16 papers receiving 974 citations

Hit Papers

Mutations in the Cystic Fibrosis Gene in Patients with Co... 1995 2026 2005 2015 1995 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Claustres France 9 517 308 227 125 115 18 1.0k
P Malet France 15 92 0.2× 336 1.1× 214 0.9× 51 0.4× 119 1.0× 65 768
Tahsin Yakut Türkiye 15 72 0.1× 315 1.0× 191 0.8× 83 0.7× 174 1.5× 78 762
Sevilhan Artan Türkiye 18 75 0.1× 308 1.0× 187 0.8× 156 1.2× 104 0.9× 84 760
Jason D. Engel United States 18 324 0.6× 718 2.3× 130 0.6× 80 0.6× 86 0.7× 39 1.5k
G. Kohnen United Kingdom 15 126 0.2× 288 0.9× 61 0.3× 138 1.1× 491 4.3× 26 1.2k
Hanne Rose Denmark 14 109 0.2× 318 1.0× 480 2.1× 38 0.3× 178 1.5× 30 900
Valentina Fiano Italy 18 206 0.4× 555 1.8× 50 0.2× 112 0.9× 34 0.3× 47 971
Yiming Xing United States 16 500 1.0× 564 1.8× 122 0.5× 33 0.3× 36 0.3× 30 978
Lesa Nelson United States 17 144 0.3× 205 0.7× 247 1.1× 127 1.0× 226 2.0× 31 1.3k
Patricia A. Aronin United States 13 210 0.4× 133 0.4× 38 0.2× 271 2.2× 69 0.6× 25 733

Countries citing papers authored by M. Claustres

Since Specialization
Citations

This map shows the geographic impact of M. Claustres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Claustres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Claustres more than expected).

Fields of papers citing papers by M. Claustres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Claustres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Claustres. The network helps show where M. Claustres may publish in the future.

Co-authorship network of co-authors of M. Claustres

This figure shows the co-authorship network connecting the top 25 collaborators of M. Claustres. A scholar is included among the top collaborators of M. Claustres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Claustres. M. Claustres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tapon‐Bretaudière, Jacqueline, et al.. (2012). Lethal factor VII deficiency due to novel mutations in the F7 promoter: Functional analysis reveals disruption of HNF4 binding site. Thrombosis and Haemostasis. 108(8). 277–283. 6 indexed citations
2.
Barat‐Houari, Mouna, Karine Nguyen, Rafaëlle Bernard, et al.. (2009). New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?. European Journal of Human Genetics. 18(5). 533–538. 11 indexed citations
3.
Romey, Marie‐Catherine, et al.. (2008). Direct carrier testing of haemophilia B by SSCP. Clinical & Laboratory Haematology. 16(1). 15–20.
4.
Girodon, E., et al.. (2008). Occurrence of CFTR de novo mutations is not so rare. Journal of Cystic Fibrosis. 7. S6–S6. 4 indexed citations
5.
Pennarun, Erwan, Toomas Kivisild, Kristiina Tambets, et al.. (2007). An mtDNA perspective of French genetic variation. Annals of Human Biology. 34(1). 68–79. 50 indexed citations
6.
Guittard, Caroline, et al.. (2007). 359 Negative genetic neonatal screening for cystic fibrosis caused by compound heterozygosity for two large CFTR rearrangements. Journal of Cystic Fibrosis. 6. S88–S88. 4 indexed citations
7.
Soussi, Thierry, Chikashi Ishioka, M. Claustres, & Christophe Béroud. (2006). Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nature reviews. Cancer. 6(1). 83–90. 102 indexed citations
8.
Guittard, Caroline, B Arnaud, Jacques Demaille, et al.. (2000). BIGH3 exon 14 mutations lead to intermediate type I/IIIA of lattice corneal dystrophies.. PubMed. 41(6). 1302–8. 78 indexed citations
9.
Griffoin, Jean‐Michel, Corinne Bareil, Sarah Bonnet, et al.. (2000). [Molecular genetics of pigmentary retinopathies: identification of mutations in CHM, RDS, RHO, RPE65, USH2A and XLRS1 genes].. Journal Français d Ophtalmologie. 23(10). 985–95. 18 indexed citations
10.
Tuffery‐Giraud, Sylvie, et al.. (1999). Point mutations in the dystrophin gene: Evidence for frequent use of cryptic splice sites as a result of splicing defects. Human Mutation. 14(5). 359–368. 43 indexed citations
11.
Girardet, Anne, et al.. (1998). [Retinoblastoma: importance of genetic counseling].. PubMed. 21(4). 295–301. 2 indexed citations
12.
Biron, Christine A., et al.. (1997). Diagnosis strategies in activated protein C resistance: is genotyping still necessary?. Clinical & Laboratory Haematology. 19(1). 67–71. 9 indexed citations
13.
Hamel, Christian, et al.. (1997). An exonic polymorphism (381A/G) in the choroideremia gene.. PubMed. 8(3). 223–5. 1 indexed citations
14.
Claustres, M., Marie Desgeorges, Philippe Le Moine, Núria Morral, & Xavier Estivill. (1996). CFTR haplotypic variability for normal and mutant genes in cystic fibrosis families from southern France. Human Genetics. 98(3). 336–344. 25 indexed citations
15.
Girardet, Anne, M. Claustres, & Franck Pellestor. (1996). Typage génique des spermatozoïdes : application à l'étude du génome. médecine/sciences. 12(12). 1389–1389.
16.
Chillón, Miguel, Teresa Casals, Bernard Mercier, et al.. (1995). Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas Deferens. New England Journal of Medicine. 332(22). 1475–1480. 680 indexed citations breakdown →
17.
Aguilar‐Martinez, Patricia, Nelly Fabre, Robert Navarro, et al.. (1993). DNA analysis of haemophilia A families from southern France. Experience of a hospital laboratory.. PubMed. 4(4). 311–9. 1 indexed citations
18.
Claustres, M., et al.. (1984). [Ferritin and breast cancer].. PubMed. 32(4). 265–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026